Successful Micro Stent II Launch Drives 592% Revenue Surge For AVE
This article was originally published in The Gray Sheet
Executive Summary
Arterial Vascular Engineering's $106 mil. in coronary stent domestic revenue in the third quarter of fiscal 1998 (ended March 31) was the primary force behind a 592% spike in corporate volume to $141 mil.